Ibutop Gel 50 Mg/G Gel (Ibuprofen)

Ibuprofen in the gel inhibits the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes in peripheral tissues. By reducing prostaglandin synthesis, it diminishes the biochemical signals that cause inflammation, pain, and fever, delivering a localized therapeutic effect when the gel is applied to the skin.

The appropriate amount of Ibutop Gel to apply is set by the prescribing healthcare professional based on the severity of symptoms, the size of the treatment area, and patient‑specific factors. Patients should follow the prescriber’s instructions and not exceed the recommended application frequency.

The safety of topical ibuprofen during pregnancy or lactation has not been definitively established. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before using Ibutop Gel to weigh potential risks and benefits.

To order Ibutop Gel, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ibutop Gel delivers ibuprofen directly to the skin, providing localized relief with minimal systemic exposure, whereas oral ibuprofen distributes throughout the body and may carry higher risks of gastrointestinal and cardiovascular side effects. Topical use is often preferred for isolated joint or muscle pain when systemic effects are a concern.

Store Ibutop Gel at ambient temperature, preferably below 25 °C (77 °F). Keep the container tightly closed, protect it from moisture and direct sunlight, and retain it in its original packaging to maintain product stability.

Clean and dry the affected skin area before use. Apply a thin layer of the gel to the site and gently massage until it is absorbed. Follow the prescriber’s recommended frequency, typically not more than three to four applications per day, and avoid covering the area with occlusive dressings unless instructed.

Serious risks, though rare, include systemic NSAID effects such as gastrointestinal bleeding, allergic reactions like hives or angioedema, and severe skin conditions such as Stevens‑Johnson syndrome. Patients should discontinue use and seek medical attention if they notice signs of a serious reaction.

Individuals with known hypersensitivity to ibuprofen, other NSAIDs, or any component of the gel should avoid its use. It should also not be applied to broken, infected or inflamed skin, and it is not recommended for children under 12 years of age without professional guidance.